Institute for Frontier Science Initiative Interdisciplinary Seminar
"Mechanism of action of thrombocytopenia drugs with radiation damage reduction"

Event Details

While radiation is widely used in cancer treatment and research, it is also known to damage normal cells. Thrombocytopenia is one of the most important side effects that occur after radiation exposure. In recent years, some drugs used to treat thrombocytopenia have been found to reduce radiation-induced tissue damage, which has attracted attention as a new function of existing drugs. However, the mechanism by which these drugs suppress radiation damage is still poorly understood.

Professor Ikuo Kashiwakura, Hirosaki University, is involved in various activities related to "radiation exposure medicine" to restore individuals and cells exposed to strong radiation. In this lecture, he will focus on thrombocytopenia drugs with radiation damage reduction effects, and explain their pharmacological actions and mechanisms of action with experimental data.

We hope that through this lecture, you will deepen your understanding of the fundamentals of radiobiology and pharmacology as well as the new potential applications of existing drugs.

Contact

Kanazawa University, Institute for Frontier Science Initiative, Cell Bionomics Unit, Associate Professor Masaharu Hazawa    E-mail: mhazawa(a)staff.kanazawa-u.ac.jp
Biomass Refinery Unit, Associate Professor Yota Tsuge    E-mail: ytsuge(a)staff.kanazawa-u.ac.jp
Please replace (a) with @.